Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Genomics England Ltd (GEL) is delivering a Cancer 2.0 programme of work aiming to explore how research, diagnosis and care for cancer patients can be optimised through a number of ground-breaking initiatives. The programme of work includes a 'long-read' workstream which aims to pilot the new technology within the NHS Genomics Laboratory Hubs (GLHs). In order to be a success, the long-read workstream must rapidly build a pipeline of long-read genomes through acquiring samples, analysing them and relaying the data back to the NHS.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| PA CONSULTING (UK) LIMITED | 06319664 | £70,000 | - |